Literature DB >> 3970900

Structure-function studies of canine cardiac sarcolemmal membranes. II. Structural organization of the sarcolemmal membrane as determined by electron microscopy and lamellar X-ray diffraction.

L G Herbette, T MacAlister, T F Ashavaid, R A Colvin.   

Abstract

The morphological and ultrastructural properties of highly purified canine cardiac sarcolemmal vesicles, prepared by a modification (Colvin, R.A., Ashavaid, T.F. and Herbette, L.G. (1985) Biochim. Biophys. Acta 812, 601-608) of the method of Jones et al. (Jones L.R., Madlock, S.W. and Besch, H.R. (1980) J. Biol. Chem. 255, 9971-9980), were examined by several techniques. Thin-section electron microscopy showed predominantly intact unilamellar vesicles with little staining beyond the lipid bilayer boundaries. Freeze-fracture electron microscopy demonstrated that the majority of particles are approx. 90 A diameter and present at a density of 780 +/- 190 micrometers-2 (+/- S.D.). If it is assumed that some of these particles represent the (Na+ + K+)-ATPase, the finding that they are largely confined to the convex fracture face suggests a predominant right-side-out orientation of these sarcolemmal vesicles that is consistent with biochemical assays. The sarcolemmal membrane width measured by electron microscopy (unhydrated membrane width of 50-70 A) is consistent with the unit cell dimensions of 56-77 A determined by lamellar X-ray diffraction (hydrated membrane width). A unit cell dimension of 56-62 A was also found by X-ray diffraction for sarcolemmal lipids extracted from these preparations, indicating that the isolated sarcolemmal preparations do not contain a significant surface coat (glycocalyx). As both cardiac and skeletal sarcoplasmic reticulum membranes have a 80-100 A membrane width, these findings demonstrate that the purified sarcolemmal membrane is structurally distinct from both cardiac and skeletal sarcoplasmic reticulum. In contrast to the protein-rich skeletal sarcoplasmic reticulum membrane, which contains a single essential protein responsible for the regulation of cytosolic Ca2+ concentration, the sarcolemma is a lipid-rich membrane that contains a variety of proteins associated with many regulatory functions served by this membrane in cardiac muscle.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3970900     DOI: 10.1016/0005-2736(85)90254-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Structural analysis of drug molecules in biological membranes.

Authors:  L G Herbette; D W Chester; D G Rhodes
Journal:  Biophys J       Date:  1986-01       Impact factor: 4.033

2.  Partitioning and location of Bay K 8644, 1,4-dihydropyridine calcium channel agonist, in model and biological membranes.

Authors:  R P Mason; G E Gonye; D W Chester; L G Herbette
Journal:  Biophys J       Date:  1989-04       Impact factor: 4.033

3.  Diffusional dynamics of an active rhodamine-labeled 1,4-dihydropyridine in sarcolemmal lipid multibilayers.

Authors:  R P Mason; D W Chester
Journal:  Biophys J       Date:  1989-12       Impact factor: 4.033

4.  Rat cerebral cortical synaptoneurosomal membranes. Structure and interactions with imidazobenzodiazepine and 1,4-dihydropyridine calcium channel drugs.

Authors:  J Moring; W J Shoemaker; V Skita; R P Mason; H C Hayden; R M Salomon; L G Herbette
Journal:  Biophys J       Date:  1990-08       Impact factor: 4.033

5.  X-ray diffraction analysis of cytochrome b5 reconstituted in egg phosphatidylcholine vesicles.

Authors:  L M Rzepecki; P Strittmatter; L G Herbette
Journal:  Biophys J       Date:  1986-04       Impact factor: 4.033

6.  Structure and location of amiodarone in a membrane bilayer as determined by molecular mechanics and quantitative x-ray diffraction.

Authors:  M Trumbore; D W Chester; J Moring; D Rhodes; L G Herbette
Journal:  Biophys J       Date:  1988-09       Impact factor: 4.033

7.  Molecular basis for the inhibition of 1,4-dihydropyridine calcium channel drugs binding to their receptors by a nonspecific site interaction mechanism.

Authors:  H S Young; V Skita; R P Mason; L G Herbette
Journal:  Biophys J       Date:  1992-05       Impact factor: 4.033

8.  Synergistic effect of amlodipine and atorvastatin in reversing LDL-induced endothelial dysfunction.

Authors:  R Preston Mason; Ruslan Kubant; Gehan Heeba; Robert F Jacob; Charles A Day; Yehudi S Medlin; Philipp Funovics; Tadeusz Malinski
Journal:  Pharm Res       Date:  2007-12-18       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.